Developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax, this is a next generation coronavirus vaccine administered through a needle-free ‘injection’ – a blast of air that delivers it into the skin. This offers a possible future alternative to people who fear needle-based jabs. If successful, it could be scaled […]
University of Cambridge: Cambridge coronavirus vaccine enters clinical trial
- Post author:admin
- Post published:January 5, 2022
- Post category:Uncategorized
Tags: Education News